Treatment of cutaneous T-cell lymphoma: An update
James W. Young
Abstract
James W. Young
Abstract
Cutaneous T-cell lymphoma is a malignancy of T cells that have an affinity for the skin. Prognosis and treatment depend on accurate staging using the TNM system. Treatment for stage I disease, which includes oral methoxsalen plus ultraviolet radiation (with or without retinoids), nitrogen mustard, total skin electron beam, and photopheresis, is generally helpful. Therapy for stage II, III, or IV disease is not as successful. Extracorporeal photopheresis is an exciting new treatment that perhaps offers help for certain cases of advanced disease. Despite current modes of treatment, cutaneous T-cell lymphoma frequently results in death.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Cutaneous T-cell lymphoma is a malignancy of T cells that have an affinity for the skin. Prognosis and treatment depend on accurate staging using the TNM system. Treatment for stage I disease, which includes oral methoxsalen plus ultraviolet radiation (with or without retinoids), nitrogen mustard, total skin electron beam, and photopheresis, is generally helpful. Therapy for stage II, III, or IV disease is not as successful. Extracorporeal photopheresis is an exciting new treatment that perhaps offers help for certain cases of advanced disease. Despite current modes of treatment, cutaneous T-cell lymphoma frequently results in death.
Key concepts: Medicine, Lymphoma, Dermatology, Cutaneous T-cell lymphoma, Internal medicine, Mycosis fungoides